Revenue | ₹13.61Cr |
Net Profits | ₹0.12Cr |
Net Profit Margins | 0.88% |
Concord Drugs Ltd’s revenue jumped 16.42% since last year same period to ₹13.61Cr in the Q1 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 30.87% jump in its revenue since last 3-months.
Concord Drugs Ltd’s net profit jumped 300% since last year same period to ₹0.12Cr in the Q1 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 200% jump in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin jumped 243.57% since last year same period to 0.88% in the Q1 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 129.24% jumped in its net profit margins since last 3-months.
The revenue for Concord Drugs Ltd in the Q1 results 2025 was ₹13.61Cr.
The net profit for Concord Drugs Ltd in the Q1 results 2025 was ₹0.12Cr.
The net profit margin for Concord Drugs Ltd in the Q1 results 2025 was 0.88%.
The revenue for Concord Drugs Ltd in the Q1 results 2024 was ₹11.69Cr.
The net profit for Concord Drugs Ltd in the Q1 results 2024 was ₹0.03Cr.
The net profit margin for Concord Drugs Ltd in the Q1 results 2024 was 0.26%.